BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2019
View Archived Issues
Soricimed provides update on its PDC program, including in vivo data for SBI-1301
Read More
OAT-1746, a novel arginase inhibitor, reduces tumor growth in murine glioma models
Read More
Allopregnanolone affects metabolic and lipid pathways in Alzheimer's disease
Read More
BARDA exercises option to support Qpex product development
Read More
BioMarin reports encouraging final phase III data for vosoritide in children with achondroplasia
Read More
FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326
Read More
Health Canada approves Erleada for the treatment of mCSPC
Read More
First patient enrolled in pivotal phase III InnovAATe study of Kamada's inhaled AAT
Read More
Sanofi presents data from phase I repeat-dosing study of BIVV-001
Read More
Pharmacokinetic and antidrug antibody status of ABP-959 biosimilar compared to eculizumab
Read More
Phase Ib results for PVX-410 vaccine in combination with durvalumab in TNBC
Read More
SM-08502 demonstrates promising activity in TNBC models
Read More
Macrophage activity backfires in S. aureus infection
Read More
Phase III GEMINI study of AXS-05 in MDD achieves primary endpoint
Read More
BeiGene presents cohort 1 results of ASPEN study of zanubrutinib in Waldenstrom's macroglobulinemia
Read More
Amgen discloses new KRAS G12C inhibitors
Read More
TAM receptor family tyrosine kinase inhibitors patented by Rigel Pharmaceuticals
Read More
VenatoRx Pharmaceuticals identifies new carbapenems
Read More
Merck & Co. presents new IDO-1 inhibitors
Read More
New HIV integrase inhibitors identified at Shionogi
Read More
[18F]GTP-1 imaging shown to be useful to detect cognitive decline
Read More
Study shows causal link between elevated activity of type 1 interferon and human disease
Read More
Tonix to advance development of TNX-601 CR for depression and PTSD
Read More
Medivir ends phase II colorectal cancer study of birinapant with pembrolizumab for futility
Read More
FDA approves Xtandi for metastatic castration-sensitive prostate cancer
Read More
Antisense Therapeutics plans to advance ATL-1102 into phase IIb for DMD
Read More